4.8 Article

Continuous high-titer HIV-1 vector production

Journal

NATURE BIOTECHNOLOGY
Volume 21, Issue 5, Pages 569-572

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nbt815

Keywords

-

Ask authors/readers for more resources

Human immunodeficiency virus type 1 (HIV-1)-based vectors are currently made by transient transfection, or using packaging cell lines in which expression of HIV-1 Gag and Pol proteins is induced(1-3). Continuous vector production by cells in which HIV-1 Gag-Pol is stably expressed would allow rapid and reproducible generation of large vector batches. However, attempts to make stable HIV-1 packaging cells by transfection of plasmids encoding HIV-1 Gag-Pol have resulted in cells which secrete only low levels of p24 antigen (20-80 ng/ml)(4-6), possibly because of the cytotoxicity of HIV-1 protease(7). Infection of cells with HIV-1 can result in stable virus production(8); cell clones that produce up to 1,000 ng/ml secreted p24 antigen have been described(9). Here we report that expression of HIV-1 Gag-Pol by a murine leukemia virus (MLV) vector allows constitutive, long-term, high-level (up to 850 ng/ml p24) expression of HIV-1 Gag. Stable packaging cells were constructed using codon-optimized HIV-1 GagPol(10) and envelope proteins of gammaretroviruses; these producer cells could make up to 10(7) 293T infectious units (i.u.)/ml (20 293T i.u./cell/day) for at least three months in culture.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available